Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: a pilot randomized controlled trial.
Open accessAbstract
OBJECTIVE: The United States is amidst an opioid epidemic, including synthetic opioids that may result in rapid death, leaving minimal opportunity for bystander rescue. We pilot tested a behavioral intervention to reduce the occurrence of opioid overdose among opioid dependent persons at high-risk for subsequent overdose. MATERIALS AND METHODS: We conducted a single-blinded randomized-controlled trial of a repeated dose motivational interviewing intervention (REBOOT) to reduce overdose versus treatment as usual, defined as information and referrals, over 16 months at the San Francisco Department of Public Health from 2014-2016. Participants were 18-65 years of age, had opioid use disorder by Structured Clinical Interview, active opioid use, opioid overdose within 5 years, and prior receipt of naloxone kits. The intervention was administered at months 0, 4, 8, and 12, preceded by the assessment which was also administered at month 16. Dual primary outcomes were any overdose event and number of events, collected by computer-assisted personal interview, as well as any fatal overdose events per vital records. RESULTS: A total of 78 persons were screened and 63 enrolled. Mean age was 43 years, 67% were born male, 65% White, 17% African-American, and 14% Latino. Ninety-two percent of visits and 93% of counseling sessions were completed. At baseline, 33.3% of participants had experienced an overdose in the past four months, with a similar mean number of overdoses in both arms (p = 0.95); 29% overdosed during follow-up. By intention-to-treat, participants assigned to REBOOT were less likely to experience any overdose (incidence rate ratio [IRR] 0.62 [95%CI 0.41-0.92, p = 0.019) and experienced fewer overdose events (IRR 0.46, 95%CI 0.24-0.90, p = 0.023), findings that were robust to sensitivity analyses. There were no differences between arms in days of opioid use, substance use treatment, or naloxone carriage. CONCLUSIONS: REBOOT reduced the occurrence of any opioid overdose and the number of overdoses. TRIAL REGISTRATION: clinicaltrials.gov NCT02093559.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,767 · see citing works
The brief symptom inventory: an introductory report.
Derogatis, L. R., & Melisaratos, N. (1983) · Psychological Medicine · doi:10.1017/s0033291700048017 · Cited by 6,650 · see citing works
Fisher, J. D., & Fisher, W. A. (1992) · Psychological Bulletin · doi:10.1037/0033-2909.111.3.455 · Cited by 2,459 · see citing works
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194 · see citing works
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,350 · see citing works
Gossop, M., Darke, S. G., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995) · Addiction · doi:10.1046/j.1360-0443.1995.9056072.x · Cited by 1,341 · see citing works
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ · doi:10.1136/bmj.f174 · Cited by 999 · see citing works
Kamb, M. L., Fishbein, M., Douglas, Jr., Rhodes, F., Rogers, J., Bolan, G., Zenilman, J., Hoxworth, T., Malotte, C. K., Iatesta, M., et al. (1998) · JAMA · doi:10.1001/jama.280.13.1161 · Cited by 973 · see citing works
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
(2011) · PubMed · Cited by 640 · see citing works
Theoretical Approaches to Individual-Level Change in HIV Risk Behavior
Fisher, J. D., & Fisher, W. A. (2000) · AIDS prevention and mental health · doi:10.1007/978-1-4615-4137-0_1 · Cited by 505 · see citing works
Gossop, M., Darke, S. G., Griffiths, P., et al. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb02199.x · Cited by 500 · see citing works
Mortality in the United States, 2024
Xu, J., Murphy, S. L., Kochanek, K. D., & Arias, E. (2026) · doi:10.15620/cdc/174641 · Cited by 461 · see citing works
Initiation into prescription opioid misuse amongst young injection drug users
Lankenau, S. E., Teti, M., Silva, K., Bloom, J. J., Harocopos, A., & Treese, M. (2012) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2011.05.014 · Cited by 440 · see citing works
HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention.
Latkin, C. A., Sherman, S. G., & Knowlton, A. R. (2003) · Health Psychology · doi:10.1037/0278-6133.22.4.332 · Cited by 348 · see citing works
Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal
Coffin, P. O., & Sullivan, S. D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-1-201301010-00003 · Cited by 347 · see citing works
Sporer, K. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00019 · Cited by 338 · see citing works
Coffin, P. O., Galea, S., Ahern, J., Leon, A. C., Vlahov, D., & Tardiff, K. J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00376.x · Cited by 334 · see citing works
Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016
Somerville, N. J., O’Donnell, J. K., Gladden, R. M., Zibbell, J. E., Green, T. C., Younkin, M., Ruiz, S., Babakhanlou‐Chase, H., Chan, M., Callis, B. P., et al. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6614a2 · Cited by 291 · see citing works
(2000) · AIDS prevention and mental health · doi:10.1007/978-1-4615-4137-0 · Cited by 260 · see citing works
Unick, G. J., Rosenblum, D., Mars, S. G., & Ciccarone, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054496 · Cited by 255 · see citing works
(2013) · PubMed Central · Cited by 254 · see citing works
Bird, S. M., McAuley, A., Perry, S., & Hunter, C. (2016) · Addiction · doi:10.1111/add.13265 · Cited by 248 · see citing works
Prescribing Naloxone to Actively Injecting Heroin Users: A Program to Reduce Heroin Overdose Deaths
Maxwell, S., Bigg, D., Stanczykiewicz, K., & Carlberg-Racich, S. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25n03_11 · Cited by 242 · see citing works
Mortality in the United States, 1900-1950
Gordon, T. (1953) · Public Health Reports (1896-1970) · doi:10.2307/4588443 · Cited by 222 · see citing works
Morbidity associated with non‐fatal heroin overdose
Warner‐Smith, M., Darke, S. G., & Day, C. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00132.x · Cited by 209 · see citing works
Metsch, L. R., Feaster, D. J., Gooden, L. K., Matheson, T., Stitzer, M. L., Das, M., Jain, M. K., Rodriguez, A. E., Armstrong, W. S., Lucas, G. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.8914 · Cited by 191 · see citing works
Coffin, P. O., Behar, E., Rowe, C. L., Santos, G., Coffa, D. A., Bald, M. R., & Vittinghoff, E. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2771 · Cited by 189 · see citing works
Direct Costs of Opioid Abuse in an Insured Population in the United States
White, A. G., Birnbaum, H. G., Mareva, M. N., Daher, M., Vallow, S., Schein, J. R., & Katz, N. P. (2005) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2005.11.6.469 · Cited by 180 · see citing works
Stoove, M. A., Dietze, P., & Jolley, D. (2009) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00057.x · Cited by 170 · see citing works
Direct Costs of Opioid Abuse in an Insured Population in the United States
White, A. G., Birnbaum, H. G., Mareva, M. N., Daher, M., Vallow, S., Schein, J. R., & Katz, N. P. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.10.1188 · Cited by 169 · see citing works
Identifying Injection Drug Users at Risk of Nonfatal Overdose
Coffin, P. O., Tracy, M., Bucciarelli, A., Ompad, D. C., Vlahov, D., & Galea, S. (2007) · Academic Emergency Medicine · doi:10.1197/j.aem.2007.04.005 · Cited by 161 · see citing works
Garfein, R. S., Golub, E. T., Greenberg, A. E., Hagan, H., Hanson, D. L., Hudson, S. M., Kapadia, F., Latka, M. H., Ouellet, L. J., Purcell, D. W., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32823f9066 · Cited by 159 · see citing works
Bennett, A. S., Bell, A., Tomedi, L. E., Hulsey, E. G., & Kral, A. H. (2011) · Journal of Urban Health · doi:10.1007/s11524-011-9600-7 · Cited by 158 · see citing works
Pierce, M., Bird, S. M., Hickman, M., Marsden, J., Dunn, G., Jones, A., & Millar, T. (2015) · Addiction · doi:10.1111/add.13193 · Cited by 155 · see citing works
Economic Burden of Prescription Opioid Misuse and Abuse
Strassels, S. A. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.7.556 · Cited by 148 · see citing works
Young, A. M., & Havens, J. R. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03635.x · Cited by 143 · see citing works
Evaluation of a Naloxone Distribution and Administration Program in New York City
Piper, T. M., Stancliff, S., Rudenstine, S., Sherman, S. G., Nandi, V., Clear, A., & Galea, S. (2008) · Substance Use & Misuse · doi:10.1080/10826080701801261 · Cited by 130 · see citing works
Metsch, L. R., Feaster, D. J., Gooden, L., Schackman, B. R., Matheson, T., Das, M., Golden, M. R., Huffaker, S., Haynes, L. F., Tross, S., et al. (2013) · JAMA · doi:10.1001/jama.2013.280034 · Cited by 130 · see citing works
Peavy, K. M., Banta‐Green, C. J., Kingston, S., Hanrahan, M. T., Merrill, J. O., & Coffin, P. O. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.704591 · Cited by 128 · see citing works
Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse?
Burns, G., DeRienz, R. T., Baker, D. D., Casavant, M., & Spiller, H. A. (2016) · Clinical Toxicology · doi:10.3109/15563650.2016.1157722 · Cited by 126 · see citing works
Counterfeit Medications and Fentanyl
Green, T. C., & Gilbert, M. K. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.4310 · Cited by 125 · see citing works
Non-fatal overdose and subsequent drug treatment among injection drug users
Pollini, R. A., McCall, L. D., Mehta, S. H., Vlahov, D., & Strathdee, S. A. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.10.015 · Cited by 124 · see citing works
Injection Drug Users Trained by Overdose Prevention Programs: Responses to Witnessed Overdoses
Lankenau, S. E., Wagner, K. D., Silva, K., Kecojević, A., Iverson, E., McNeely, M., & Kral, A. H. (2012) · Journal of Community Health · doi:10.1007/s10900-012-9591-7 · Cited by 123 · see citing works
Tobin, K. E., Kuramoto, S. J., Davey-Rothwell, M. A., & Latkin, C. A. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03146.x · Cited by 119 · see citing works
Mortality in the United States, 2015.
Xu, J., Murphy, S. L., Kochanek, K. D., & Arias, E. (2016) · PubMed · Cited by 119 · see citing works
Darke, S. G., Mills, K. L., Ross, J. E., & Teesson, M. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.10.021 · Cited by 113 · see citing works
Mortality Among Young Injection Drug Users in San Francisco: A 10-Year Follow-up of the UFO Study
Evans, J. L., Tsui, J. I., Hahn, J. A., Davidson, P. J., Lum, P. J., & Page, K. A. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr318 · Cited by 113 · see citing works
The Economic Burden of Opioid-Related Poisoning in the United States
Inocencio, T. J., Carroll, N. V., Read, E. J., & Holdford, D. A. (2013) · Pain Medicine · doi:10.1111/pme.12183 · Cited by 110 · see citing works
Heroin overdose among young injection drug users in San Francisco
Ochoa, K. C., Davidson, P. J., Evans, J. L., Hahn, J. A., Page, K. A., & Moss, A. R. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.04.012 · Cited by 101 · see citing works
Sherman, S. G., Sutcliffe, C. G., Srirojn, B., Latkin, C. A., Aramratana, A., & Celentano, D. D. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.09.061 · Cited by 94 · see citing works
Overdose after detoxification: A prospective study☆
Wines, J. D., Saitz, R., Horton, N. J., Lloyd-Travaglini, C. A., & Samet, J. H. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.12.019 · Cited by 90 · see citing works
Darke, S. G., Williamson, A., Ross, J. E., Mills, K. L., Havard, A., & Teesson, M. (2007) · Journal of Urban Health · doi:10.1007/s11524-006-9156-0 · Cited by 82 · see citing works
Risk Factors for Nonfatal Overdose at Seattle-Area Syringe Exchanges
Jenkins, L. M., Banta‐Green, C. J., Maynard, C. C., Kingston, S., Hanrahan, M. T., Merrill, J. O., & Coffin, P. O. (2011) · Journal of Urban Health · doi:10.1007/s11524-010-9525-6 · Cited by 81 · see citing works
Darke, S. G., Williamson, A. B., Ross, J. E., & Teesson, M. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500286005 · Cited by 74 · see citing works
From evidence to policy: The Scottish national naloxone programme
McAuley, A., Best, D. W., Taylor, A., Hunter, C., & Robertson, R. (2012) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2012.682232 · Cited by 65 · see citing works
Reducing HIV infection among new injecting drug users in the China–Vietnam Cross Border Project
Jarlais, D. C. D., Kling, R. N., Hammett, T. M., Ngu, D., Liu, W., Chen, Y., Binh, K. T., & Friedmann, P. (2007) · AIDS · doi:10.1097/01.aids.0000304705.79541.34 · Cited by 56 · see citing works
(2011) · PubMed · Cited by 55 · see citing works
Metcalf, C. A., Malotte, C. K., Douglas, J. M., Paul, S. M., Dillon, B. A., Cross, H., Brookes, L. C., DeAugustine, N., Lindsey, C., Byers, R. H., et al. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000151420.92624.c0 · Cited by 51 · see citing works
Cherpitel, C. J., Korcha, R. A., Moskalewicz, J., Swiatkiewicz, G., Ye, Y., & Bond, J. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01281.x · Cited by 45 · see citing works
Times and Places: Process Evaluation of a Peer-Led HIV Prevention Intervention
Dickson‐Gómez, J., Weeks, M. R., Martinez, M., & Convey, M. (2006) · Substance Use & Misuse · doi:10.1080/10826080500411403 · Cited by 43 · see citing works
O’Brien, C. P., Gastfriend, D. R., Forman, R. F., Schweizer, E. E., & Pettinati, H. M. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00107.x · Cited by 36 · see citing works
Treatment of opioid overdose in a physician-based prehospital EMS: Frequency and long-term prognosis
Nielsen, K., Loumann-Nielsen, S., Siersma, V., & Rasmussen, L. S. (2011) · Resuscitation · doi:10.1016/j.resuscitation.2011.05.027 · Cited by 28 · see citing works
Mackesy‐Amiti, M. E., Ouellet, L. J., Golub, E. T., Hudson, S., Hagan, H., & Garfein, R. S. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03251.x · Cited by 26 · see citing works
Agents of Change: Peer Mentorship as HIV Prevention Among HIV-Positive Injection Drug Users
Mackenzie, S., Pearson, C., Frye, V. A., Gomez, C. A., Latka, M. H., Purcell, D. W., Knowlton, A. R., Metsch, L. R., Tobin, K. E., Valverde, E. E., et al. (2012) · Substance Use & Misuse · doi:10.3109/10826084.2012.644122 · Cited by 21 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [62]Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013; 158(1): 1– 9. doi: 10.7326/0003-4819-158-1-201301010-00003. 23277895 · DOI
Cited by
Sorted by citations
Understanding Links among Opioid Use, Overdose, and Suicide.
Bohnert, A., & Ilgen, M. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1802148 · Cited by 255 · see citing works
Bazzi, A. R., Biancarelli, D. L., Childs, E., Drainoni, M., Edeza, A., Salhaney, P., Mimiaga, M. J., & Biello, K. B. (2018) · AIDS Patient Care and STDs · doi:10.1089/apc.2018.0126 · Cited by 118 · see citing works
Evidence for state, community and systems-level prevention strategies to address the opioid crisis
Haegerich, T. M., Jones, C. M., Cote, P.-O., Robinson, A. B., & Ross, L. B. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107563 · Cited by 89 · see citing works
Calcaterra, S. L., Binswanger, I. A., Edelman, E. J., McNair, B. K., Wakeman, S. E., & O’Connor, P. G. (2020) · Substance Abuse · doi:10.1080/08897077.2020.1748169 · Cited by 40 · see citing works
Characteristics of post-overdose public health-public safety outreach in Massachusetts
Formica, S. W., Waye, K. M., Benintendi, A., Yan, S., Bagley, S. M., Beletsky, L. A., Carroll, J. J., Xuan, Z., Rosenbloom, D., Apsler, R., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108499 · Cited by 36 · see citing works
Gunn, C. M., Maschke, A., Harris, M. T. H., Schoenberger, S. F., Sampath, S., Walley, A. Y., & Bagley, S. M. (2020) · Addiction · doi:10.1111/add.15305 · Cited by 34 · see citing works
US Emergency Department Visits for Acute Harms From Prescription Opioid Use, 2016–2017
Lovegrove, M. C., Dowell, D., Geller, A. I., Goring, S. K., Rose, K. O., Weidle, N. J., & Budnitz, D. S. (2019) · American Journal of Public Health · doi:10.2105/ajph.2019.305007 · Cited by 31 · see citing works
Purposeful Fentanyl Use and Associated Factors among Opioid-Dependent People Who Inject Drugs
Chandra, D. K., Altice, F. L., Copenhaver, M. M., Zhou, X., DiDomizio, E. E., & Shrestha, R. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1901931 · Cited by 24 · see citing works
U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016
Geller, A. I., Dowell, D., Lovegrove, M. C., McAninch, J., Goring, S. K., Rose, K. O., Weidle, N. J., & Budnitz, D. S. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.12.009 · Cited by 23 · see citing works
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
Flam-Ross, J. M., Marsh, E., Weitz, M., Savinkina, A., Schackman, B. R., Wang, J., Madushani, R. W. M. A., Morgan, J. R., Barocas, J. A., Walley, A. Y., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.29583 · Cited by 21 · see citing works
Diet and companionship modulate pain via a serotonergic mechanism
Tran, H., Sagi, V., Jarrett, S., Palzer, E. F., Badgaiyan, R. D., & Gupta, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-81654-1 · Cited by 21 · see citing works
Endogenous opiates and behavior: 2017
Bodnar, R. J. (2019) · Peptides · doi:10.1016/j.peptides.2019.170223 · Cited by 19 · see citing works
Jones, J. D., Campbell, A. N. C., Brandt, L., Metz, V. E., Martinez, S., Wall, M. M., Corbeil, T., Andrews, H., Castillo, F., Neale, J., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109505 · Cited by 19 · see citing works
Cleland, C. M., Bennett, A. S., Elliott, L. C., Rosenblum, A., Britton, P. C., & Wolfson‐Stofko, B. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107734 · Cited by 20 · see citing works
Lintzeris, N., Monds, L. A., Bravo, M., Read, P. J., Harrod, M. E., Gilliver, R., Wood, W., Nielsen, S., Dietze, P., Lenton, S. R., et al. (2019) · Drug and Alcohol Review · doi:10.1111/dar.13015 · Cited by 19 · see citing works
McMahan, V., Arenander, J., Matheson, T., Lambert, A. M., Brennan, S., Green, T. C., Walley, A. Y., & Coffin, P. O. (2022) · JMIR Formative Research · doi:10.2196/37483 · Cited by 18 · see citing works
Bénard‐Laribière, A., Noïze, P., Girodet, P., Lassalle, R., Dureau‐Pournin, C., Droz‐Perroteau, C., Fourrier‐Réglat, A., Salvo, F., Bezin, J., & Pariente, A. (2018) · Therapies · doi:10.1016/j.therap.2018.12.007 · Cited by 12 · see citing works
Beckham, S. W., Glick, J. L., Schneider, K. E., Allen, S. T., Shipp, L., White, R. H., Park, J. N., & Sherman, S. G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19073783 · Cited by 11 · see citing works
Doran, K. M., Torsiglieri, A., Blaufarb, S., Hernandez, P. A., Melnick, E., Velez, L., Cleland, C. M., Neighbors, C. J., O’Grady, M. A., & Shelley, D. (2023) · Implementation Science · doi:10.1186/s13012-023-01278-z · Cited by 9 · see citing works
Development of opioid rapid response system: Protocol for a randomized controlled trial
Jayawardene, W. P., Pezalla, A., Henderson, C., & Hecht, M. L. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106727 · Cited by 8 · see citing works
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review
de Luna, G. S., Dermid, G., & Unger, J. B. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01070-2 · Cited by 7 · see citing works
Liebschutz, J. M., Subramaniam, G., Stone, R., Appleton, N., Gelberg, L., Lovejoy, T. I., Bunting, A. M., Cleland, C. M., Lasser, K. E., Beers, D., et al. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-023-00424-8 · Cited by 6 · see citing works
Evoy, K. E., Leonard, C. E., Covvey, J. R., Ochs, L. A., Peckham, A. M., Soprano, S. E., & Reveles, K. R. (2020) · Substance Abuse Research and Treatment · doi:10.1177/1178221819894588 · Cited by 5 · see citing works
Chesin, M. S., Dave, C. V., Myers, C. E., Stanley, B., Kline, A., Monahan, M. F., Latorre, M., Hill, L. M. S., Miller, R. B., King, A. R., et al. (2022) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-022-00817-x · Cited by 5 · see citing works
Papa, C. E., McClure, E. A., McCauley, J. L., Haynes, L. F., Matheson, T., Jones, R. N., Jennings, L. K., Lawdahl, T., Ward, R. C., Brady, K. T., et al. (2024) · JMIR Research Protocols · doi:10.2196/60277 · Cited by 4 · see citing works
Overdose Research: 15 Years Later
Coffin, P. O., & Rich, J. D. (2019) · Journal of Urban Health · doi:10.1007/s11524-018-00344-y · Cited by 4 · see citing works
Sims, O. T., Wang, K., Chandler, R. D., Melton, P. A., & Truong, D. N. (2020) · Social Work in Health Care · doi:10.1080/00981389.2020.1814938 · Cited by 4 · see citing works
McNerney, N. A., Losensky, M. J., Lash, M. M., Rozaieski, K., Ortiz, D., Garcia, A. N., & Rethorn, Z. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241434 · Cited by 4 · see citing works
Harmon, Z. S., Welch, E. N., & Ruby, C. L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95601 · Cited by 5 · see citing works
Carney, T., Choi, S. K., Stephenson, R. B., Bauermeister, J. A., & Carrico, A. W. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290781 · Cited by 3 · see citing works
Direct-Care Staff Perceptions of Patient Engagement and Treatment Planning in Detox
Sharp, A., Brown, B., Shreve, T., Moore, K. A., Carlson, M., & Braughton, D. (2021) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-021-09757-1 · Cited by 3 · see citing works
Coffin, P. O., Santos, G., McMahan, V., Marti, X. L., Matheson, T., Brennan, S., Arenander, J., Robinson, M., Farley, J., Pope, E., et al. (2025) · Addiction · doi:10.1111/add.70252 · Cited by 2 · see citing works
Psychosocial Treatment Methods
Peirce, J. M., Antoine, D. G., Hammond, A. S., & KIDORF, M. S. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.25 · Cited by 2 · see citing works
Bilder, A., Kelly, L., Weir, R. L., Meredith, L. S., Griffin, B. A., Mendon, S. J., Christensen, J., & Watkins, K. E. (2026) · Psychiatric Services · doi:10.1176/appi.ps.20250723 · Cited by 1 · see citing works
Jones, J. D., Luba, R. R., Mumtaz, M., & Castillo, F. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.30 · Cited by 1 · see citing works
Reducing Overdoses Among African American Individuals in Ohio: An Emerging Public Health Crisis
Beausir, A., & King, K. A. (2023) · Ohio Journal of Public Health · doi:10.18061/ojph.v6i1.9410 · Cited by 1 · see citing works
Descriptive Analysis of the Most Viewed Youtube Videos Related to the Opioid Epidemic
Randolph-Krisova, A. (2018) · doi:10.7916/d8x36dxs · Cited by 1 · see citing works
[Examining substance use disorders in diverse service settings: Initial efficacy of the ICTUS].
Sánchez-Millán, H. A., Rivera-Suazo, S., Pérez-Pedrogo, C., & Colón, G. R. (2020) · PubMed · Cited by 1 · see citing works
Motivational interviewing for cannabis use disorders: A narrative review from research to practice
Pons-Cabrera, M. T., Salvà, C. O., Cortez, P., & López‐Pelayo, H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00032-5
Psychosocially-Assisted Pharmacological Treatment of Opioid Dependent Adults: A Systematic Review
Wayah, S. B., Waziri, P. M., Onyebuchi, C. M., Yahaya, G., & Chindo, B. A. (2022) · Ibom Medical Journal · doi:10.61386/imj.v15i3.264
Ghosh, A., Pillai, R. R., Vij, J., Maulik, P. K., Bhanker, N., Thakur, U., Rani, R., & Basu, D. (2025) · Indian Journal of Psychological Medicine · doi:10.1177/02537176241313210
Doran, K. M., Torsiglieri, A., Blaufarb, S., Hernandez, P. A., Melnick, E., Velez, L., Cleland, C. M., Neighbors, C. J., O’Grady, M. A., & Shelley, D. (2023) · Figshare · doi:10.6084/m9.figshare.23354271
Liebschutz, J. M., Subramaniam, G., Stone, R., Appleton, N., Gelberg, L., Lovejoy, T. I., Bunting, A. M., Cleland, C. M., Lasser, K. E., Beers, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26642362
McNeely, J., Subramaniam, G. A., Stone, R., Mazel, S. B., Appleton, N., Abadi, Y. R., Bunting, A. M., Shi, Y., Lovejoy, T. I., Gelberg, L., et al. (2026) · Addiction · doi:10.1111/add.70504
- Authors
- Coffin, P. O., Santos, G.-M., Matheson, T., Behar, E., Rowe, C., Rubin, T., Silvis, J., & Vittinghoff, E.
- Affiliations
- University of California, San Francisco (US)
- San Francisco Department of Public Health (US)
- Corresponding author
- Coffin, Phillip Oliver
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-10-19
- Volume
- 12
- Issue
- 10
- Pages
- e0183354
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5648110
- OpenAlex
- W2767186288
- Cited by
- 44
- References
- 64
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 8 · 2018: 3
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute on Drug Abuse (R34DA037194)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- opioid overdose, opioid use disorder, motivational interviewing, behavioral interventions, naloxone, synthetic opioids, overdose prevention, high-risk individuals, opioid epidemic
- MeSH terms
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Narcotic Antagonists, Opioid-Related Disorders, Pilot Projects, Risk Factors, Single-Blind Method, Treatment Outcome, Young Adult, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review